Special Issue "Warfarin Versus the Non-vitamin K Oral Anticoagulants (NOACs) in Clinical Practice"
Deadline for manuscript submissions: 30 May 2019
On behalf of the Journal of Clinical Medicine (JCM) editorial team, we are delighted to present a new Special Issue on the topic of “Warfarin versus the Non-Vitamin K Oral Anticoagulants (NOACs) in Clinical Practice”, Guest Edited by Associate Professor Shailendra Anoopkumar-Dukie and Ms Nijole Bernaitis from the Griffith University School of Pharmacy and Pharmacology, Gold Coast, Queensland, Australia.
Introduction of the NOACs has provided options for anticoagulant therapy for patients with thromboembolic disease. Numerous factors, including health systems, clinical patient characteristics, and both prescriber and patient preferences, now influence choice of anticoagulant and associated efficacy and safety of agents. Differences in health outcomes with individual anticoagulants may be seen according to geographic region, ethnicity, and health management systems. Knowledge and understanding of the factors influencing the quality use of anticoagulants can contribute to identifying which population groups may get most benefit from anticoagulants. This may ultimately help in optimising patient outcomes with individual anticoagulants.
This Special Issue of the Journal of Clinical Medicine aims to examine advances in optimising oral anticoagulant therapy in clinical practice with application to different settings using real-world data. Of particular interest is the evaluation of health outcomes associated with anticoagulant use in different populations. International comparative outcomes and factors influencing these outcomes from real-world or observational data may further assist selection of appropriate anticoagulation for specific populations or individuals.
Dr. Shailendra Anoopkumar-Dukie
Ms. Nijole Bernaitis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Warfarin, Rivaroxaban, Apixaban, Dabigatran, Edoxaban
- Comparative effectiveness
- Health outcomes
- Pharmacoeconomic comparison
- Real world or observational data
- Patient management
- Population health